This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
Silicon Motion Technology Corporation Sponsored ADR (SIMO) has risen 47.3% since the first of the year. Silicon Motion Technology is a semiconductor company that designs, develops, and markets semiconductor products for the multimedia consumer electronics market. For more information, get Portfolio Grader’s complete analysis of SIMO stock.
Since January 1, Impax Laboratories, Inc. (IPXL) has shot up 50.2%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. Trade volume rose notably over the past week, up 95.6%. For more information, get Portfolio Grader’s complete analysis of IPXL stock.
Shares of Skyworks Solutions, Inc. (SWKS) have risen 50.5% since January 1. Skyworks Solutions is an innovator of analog and mixed-signal semiconductors. For more information, get Portfolio Grader’s complete analysis of SWKS stock.
The price of Insperity, Inc. (NSP) has seen a 53.4% boost since the first of the year. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.
Since January 1, Ellie Mae, Inc. (ELLI) has climbed 54.1%. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.
Since January 1, the price of ABIOMED, Inc. (ABMD) has grown 62.7%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Since the first of the year, the price of China Biologic Products, Inc. (CBPO) has swelled 66.6%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. The volume of trades has grown significantly in the past week, up 207.2%. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
Shares of Skechers U.S.A., Inc. Class A (SKX) have leaped 87.4% since January 1. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.
The price of Ebix, Inc. (EBIX) is up 113.2% since the first of the year. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
Since the first of the year, shares of Chimera Investment Corporation (CIM) have soared 323.5%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock currently has a trailing PE Ratio of 5.40. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
